In Phase A, participants will receive unique doses and schedules of oral ABBV-744 pill to recognize safe dosing regimen. More contributors will likely be enrolled within the identified monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be offered as "add-on" therapy. In Section C, https://isabbv-744effectiveforhem57801.blogpayz.com/32011305/clinical-trial-recruitment-for-abbv-744-study-fundamentals-explained